NCT04965168

Brief Summary

Our study is a comparative study, that was conducted to evaluate the corneal endothelial cells changes and central corneal thickness after uncomplicated phacoemulsification and intra ocular lens (IOL) implantation in normal controls, in non-diabetic and diabetic patients with PEX, and in patients with PEX only using specular microscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 7, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2021

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2021

Completed
Last Updated

November 12, 2021

Status Verified

November 1, 2021

Enrollment Period

11 months

First QC Date

July 7, 2021

Last Update Submit

November 11, 2021

Conditions

Keywords

DMphacoemulsificationendothelial cell density

Outcome Measures

Primary Outcomes (4)

  • endothelial cell density

    number of endothelial cells

    6 months

  • Percentage of hexagonal cells

    indicator of healthy endothelial cells

    6 months

  • coefficient of variation (CV)

    indicator of the uniformity of the size of endothelial cells

    6 months

  • Central corneal thickness

    measurement of the distance between the epithelium and endothelium at the central cornea

    6 months

Study Arms (4)

controls

ACTIVE COMPARATOR

phacoemulsification and IOL implantation

Procedure: phacoemulsification of the lens

diabetic without pseudoexfoliation

ACTIVE COMPARATOR

phacoemulsification and IOL implantation

Procedure: phacoemulsification of the lens

non-diabetic with pseudoexfoliation

ACTIVE COMPARATOR

phacoemulsification and IOL implantation

Procedure: phacoemulsification of the lens

diabetic with pseudoexfoliation

ACTIVE COMPARATOR

phacoemulsification and IOL implantation

Procedure: phacoemulsification of the lens

Interventions

all patients underwent phacoemulsification and IOL implantation for immature cataract extraction

controlsdiabetic with pseudoexfoliationdiabetic without pseudoexfoliationnon-diabetic with pseudoexfoliation

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Senile cataract with age between 50 to 70 years
  • Clear cornea with no zonuler dehiscence
  • Lens opacity classification system III (LOCS III), with grade 2-3 nuclear cataract with any additional cortical (C) and posterior sub capsular (P)

You may not qualify if:

  • Uncontrolled DM in diabetic groups
  • Presence of autoimmune diseases
  • Patients with glaucoma
  • Corneal guttata
  • Zonular dehiscence
  • Rupture posterior capsule during cataract surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology department/ Minia University Hospital/Minia University

Minya, 61111, Egypt

Location

Related Publications (6)

  • Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol. 2014 Mar;92(2):158-60. doi: 10.1111/aos.12064. Epub 2013 Feb 7.

    PMID: 23387877BACKGROUND
  • Fernandez-Munoz E, Zamora-Ortiz R, Gonzalez-Salinas R. Endothelial cell density changes in diabetic and nondiabetic eyes undergoing phacoemulsification employing phaco-chop technique. Int Ophthalmol. 2019 Aug;39(8):1735-1741. doi: 10.1007/s10792-018-0995-y. Epub 2018 Jul 28.

    PMID: 30056522BACKGROUND
  • Oltulu R, Satirtav G, Kayitmazbatir ET, Bitirgen G, Ozkagnici A, Karaibrahimoglu A. Characteristics of the cornea in patients with pseudoexfoliation syndrome. Arq Bras Oftalmol. 2015 Nov-Dec;78(6):348-51. doi: 10.5935/0004-2749.20150092.

    PMID: 26677035BACKGROUND
  • Aoki T, Kitazawa K, Inatomi T, Kusada N, Horiuchi N, Takeda K, Yokoi N, Kinoshita S, Sotozono C. Publisher Correction: Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome. Sci Rep. 2020 May 26;10(1):8800. doi: 10.1038/s41598-020-66089-4.

    PMID: 32451432BACKGROUND
  • Quiroga L, Lansingh VC, Samudio M, Pena FY, Carter MJ. Characteristics of the corneal endothelium and pseudoexfoliation syndrome in patients with senile cataract. Clin Exp Ophthalmol. 2010 Jul;38(5):449-55. doi: 10.1111/j.1442-9071.2010.02313.x. Epub 2010 Apr 28.

    PMID: 20456430BACKGROUND
  • Mahmoud MSE, Omar IAN, AttaAllah HR. Evaluation of the corneal thickness and endothelial changes following uncomplicated phacoemulsification in diabetic and non-diabetic patients with pseudo-exfoliation syndrome by specular microscopy. Int Ophthalmol. 2023 Dec;43(12):4773-4780. doi: 10.1007/s10792-023-02877-x. Epub 2023 Sep 18.

Study Officials

  • Heba R AttaAllah, MD

    Faculty of Medicine, Minia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Ophthalmology

Study Record Dates

First Submitted

July 7, 2021

First Posted

July 16, 2021

Study Start

December 1, 2020

Primary Completion

October 12, 2021

Study Completion

October 16, 2021

Last Updated

November 12, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations